Table 1 Clinicopathological features of POU2F3-positive invasive breast carcinomas in a new cohort (n = 1853 [TMA] + 1 [biopsy])
No | Age | Gender | pT | pN | FU-M | Survival | Grade | Subtypes | POU2F3 | BCL2 | KIT | ER | PR | HER2 | Ki-67 | CK5 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 61 | F | NA | NA | NA | NA | 3 | Triple-negative | 60 | 0 | 80 | N | N | N | 70 | N |
2 | 56 | F | NA | NA | 37 | Alive | 3 | Triple-negative | 10 | 40 | 0 | N | N | N | 40 | N |
3 | 66 | F | 2 | 0 | NA | NA | 1 | Luminal | 10 | 80 | 0 | P | P | N | 5 | N |
4 | 72 | F | 1 | 0 | NA | NA | 2 | Luminal-HER2 | 30 | 80 | 0 | P | P | P | 5 | N |
5 | 38 | F | NA | NA | 1 | Alive | 3 | Triple-negative | 10 | 50 | 10 | N | N | N | 80 | 90 |